Literature DB >> 14612431

Cyclin D2 controls B cell progenitor numbers.

Azim Mohamedali1, Inês Soeiro, Nicholas C Lea, Janet Glassford, Lolita Banerji, Ghulam J Mufti, Eric W-F Lam, N Shaun B Thomas.   

Abstract

Cyclin D2 affects B cell proliferation and differentiation in vivo. It is rate-limiting for B cell receptor (BCR)-dependent proliferation of B cells, and cyclin D2-/- mice lack CD5+(B1) B lymphocytes. We show here that the bone marrow (BM) of cyclin D2-/- mice contains half the numbers of Sca1+B220+ B cell progenitors but normal levels of Sca1+ progenitor cells of other lineages. In addition, clonal analysis of BM from the cyclin D2-/- and cyclin D2+/+ mice confirmed that there were fewer B cell progenitors (B220+) in the cyclin D2-/- mice. In addition, the colonies from cyclin D2-/- mice were less mature (CD19lo) than those from cyclin D2+/+ mice (CD19Hi). The number of mature B2 B cells in vivo is the same in cyclin D2-/- and cyclin D2+/+ animals. Lack of cyclin D2 protein may be compensated by cyclin D3, as cyclin-dependent kinase (cdk)6 coimmunoprecipitates with cyclin D3 but not cyclin D1 from BM mononuclear cells of cyclin D2-/- mice. It is active, as endogenous retinoblastoma protein is phosphorylated at the cdk6/4-cyclin D-specific sites, S807/811. We conclude that cyclin D2 is rate-limiting for the production of B lymphoid progenitor cells whose proliferation does not depend on BCR signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612431     DOI: 10.1189/jlb.0803363

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.

Authors:  Silvia Fernández de Mattos; Abdelkader Essafi; Inês Soeiro; Alexandra M Pietersen; Kim U Birkenkamp; Corinne S Edwards; Anthony Martino; Brad H Nelson; Julia M Francis; Marius C Jones; Jan J Brosens; Paul J Coffer; Eric W-F Lam
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.

Authors:  Jonathan C Poe; Veronique Minard-Colin; Evgueni I Kountikov; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

3.  CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine.

Authors:  Wenting Lu; Cuiyun Cui; Yangyang Wang; Xiaomeng Sun; Shengnan Wang; Ming Yang; Yongli Yu; Liying Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-05       Impact factor: 4.813

4.  Cyclin D3 is selectively required for proliferative expansion of germinal center B cells.

Authors:  Matthew H Cato; Suresh K Chintalapati; Irene W Yau; Sidne A Omori; Robert C Rickert
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

5.  Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation.

Authors:  Jettanong Klaewsongkram; Yinhua Yang; Susanne Golech; Jonathan Katz; Klaus H Kaestner; Nan-Ping Weng
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

6.  CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation.

Authors:  Tony J Vanden Bush; Gail A Bishop
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

7.  Promiscuous and lineage-specific roles of cell cycle regulators in haematopoiesis.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Cell Div       Date:  2007-02-12       Impact factor: 5.130

8.  CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China.

Authors:  Ting Yin; Ling Qi; Yulan Zhou; Fancong Kong; Shixuan Wang; Min Yu; Fei Li
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 9.  Targeting cell cycle regulators in hematologic malignancies.

Authors:  Eiman Aleem; Robert J Arceci
Journal:  Front Cell Dev Biol       Date:  2015-04-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.